Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.60 |
| ▸ | APAF1 | O14727 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | RAD52 | P43351 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.47 |
| ▸ | LSS | P48449 | 1/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | APEX1 | P27695 | 3/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3005224 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| SCHEMBL1040145 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| SCHEMBL68320 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| SCHEMBL548835 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| SCHEMBL6895464 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| Cetrimonium SCHEMBL237554 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| SCHEMBL25414052 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| SCHEMBL238047 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| SCHEMBL6681513 | 1.00 | DNM1 (0.60) | DNM1APAF1HSP90AA1RAD52RECQL | |
| Hydrochloric Acid SCHEMBL18192375 | 0.98 | DNM1 (0.61) | DNM1APAF1HSP90AA1RAD52RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1090 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4046491-B1 | CONSUMER CARE PRODUCT | FMC CORP (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4171489-B1 | SANITIZING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2026-03-25 | — | — | EP | claimed |
| CN-121570389-A | Hair care composition containing vegetable-edible elaeis palm fruit oil | 澳宝化妆品（惠州）有限公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4247322-B1 | COMPOSITION FOR CARING FOR A KERATIN MATERIAL | OREAL (FR) | 2026-01-28 | — | — | EP | claimed |
| US-20250332084-A1 | PEPTIDE COMPOSITION AND RESPECTIVE USES | UNIVERSIDADE DO MINHO (PT) | 2025-10-30 | — | — | US | claimed |
| EP-4551302-B1 | HAIR CARE COMPOSITION | PROCTER & GAMBLE (US) | 2025-08-20 | — | — | EP | claimed |
| EP-3897541-B1 | HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION | UNILEVER GLOBAL IP LTD (GB) | 2025-08-13 | — | — | EP | claimed |
| CN-120131519-A | Compact stretched mask and preparation method thereof | 麦吉丽生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120035430-A | Composition for conditioning hair | 莱雅公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119925216-A | Medical and artistic relief composition suitable for sensitive muscles, application and cosmetics | 麦吉丽生物科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-8040066-B1 | Flesh illuminating device | GIRCH JR JAMES J | 2011-10-18 | — | — | US | claimed |
| EP-2314271-A2 | Stable water-in-oil emulsion system | Evonik Goldschmidt GmbH (DE) | 2011-04-27 | — | — | EP | claimed |
| US-20110091397-A1 | STABLE WATER-IN-OIL EMULSION SYSTEM | EVONIK GOLDSCHMIDT GMBH (DE) | 2011-04-21 | — | — | US | claimed |
| EP-2293767-A2 | HAIR CONDITIONING COMPOSITION CONTAINING BEHENYL TRIMETHYL AMMONIUM METHOSULFATE, AND HAVING HIGHER YIELD POINT | The Procter & Gamble Company (US) | 2011-03-16 | — | — | EP | claimed |
| US-20090324531-A1 | HAIR CONDITIONING COMPOSITION CONTAINING BEHENYL TRIMETHYL AMMONIUM METHOSULFATE, AND HAVING HIGHER YIELD POINT | THE PROCTER & GAMBLE COMPANY | 2009-12-31 | — | — | US | claimed |
| WO-2009158440-A2 | HAIR CONDITIONING COMPOSITION CONTAINING BEHENYL TRIMETHYL AMMONIUM METHOSULFATE, AND HAVING HIGHER YIELD POINT | THE PROCTER & GAMBLE COMPANY (US) | 2009-12-30 | — | — | WO | claimed |
| EP-1715837-A1 | CATIONIC CREAM BASE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-11-02 | — | — | EP | claimed |
| WO-2005063179-A1 | CATIONIC CREAM BASE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2005-07-14 | — | — | WO | claimed |
| EP-1226812-A2 | Hair mask generating heat on contact with moisture | Beiersdorf AG (DE) | 2002-07-31 | — | — | EP | claimed |
| EP-0600659-B1 | Toner and developer compositions with pyridinium compounds and tetrasubstituted ammonium salts as charge enhancing additives | XEROX CORP (US) | 1997-07-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110091397-A1 | STABLE WATER-IN-OIL EMULSION SYSTEM | C1R, F12, POLR2H | ACHE 4367/4885DNM1 3069/4885APAF1 4723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.